LACI ROBERTSON: Open Payments
NPI 1407449721 · FORT PAYNE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$800 in 47 payments from 15 companies in 2025. Trend: 2023 $637 · 2024 $816 · 2025 $800
Food & beverage: $638Education: $163
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 5 | $226 |
| Novartis Pharmaceuticals Corporation | 24 | $175 |
| Lilly USA, LLC | 4 | $83 |
| E.R. Squibb & Sons, L.L.C. | 2 | $82 |
| ABBVIE INC. | 2 | $36 |
| UCB, Inc. | 1 | $29 |
| Mallinckrodt Hospital Products Inc. | 1 | $24 |
| Amgen Inc. | 1 | $24 |
| Botanix SB Inc | 1 | $20 |
| Biofrontera Inc. | 1 | $19 |
Products named: DUPIXENT, COSENTYX, EBGLYSS, Sotyktu, SKYRIZI, Bimzelx, ACTHAR, OTEZLA.
Industry payments across AL — which companies pay providers there.
